National Institutes of Health
4 portfolio companies · $35.1M tracked · Biotechnology, Other Health Care
People interested in companies backed by National Institutes of Health can explore detailed information about its investments through specialized tracking platforms. StreetZero currently tracks 3 deals involving National Institutes of Health, totaling $27.4M across the Biotechnology and Other Health Care sectors. This data helps users understand the scope of its recent activity in private markets.
The National Institutes of Health portfolio consists of companies including Altay Therapeutics, Inc., Huxley Medical, Inc., and Opus KSD, Inc. These entities highlight the focus areas of its investments, offering insights into recent deals for researchers and investors seeking factual details on National Institutes of Health portfolio.